Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DHODH | Q02127 | 3/20 | 0.38 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | TRPV1 | Q8NER1 | 3/20 | 0.33 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.33 |
| ▸ | OPRL1 | P41146 | 3/20 | 0.32 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.32 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.32 |
| ▸ | BACE1 | P56817 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30658613 | 0.98 | DHODH (0.39) | DHODHCYP17A1CYP1A2TRPV1HSD11B1 | |
| SCHEMBL3254036 | 0.98 | DHODH (0.39) | DHODHCYP17A1CYP1A2TRPV1HSD11B1 | |
| SCHEMBL23249649 | 0.97 | DHODH (0.38) | DHODHCYP17A1CYP1A2TRPV1HSD11B1 | |
| SCHEMBL29101597 | 0.83 | DHODH (0.40) | DHODHCYP17A1CYP1A2TRPV1HSD11B1 | |
| SCHEMBL28411296 | 0.83 | DHODH (0.38) | DHODHCYP17A1CYP1A2TRPV1HSD11B1 | |
| SCHEMBL29101572 | 0.83 | DHODH (0.38) | DHODHCYP17A1CYP1A2TRPV1HSD11B1 | |
| SCHEMBL29437213 | 0.83 | DHODH (0.42) | DHODHCYP17A1CYP1A2TRPV1HSD11B1 | |
| SCHEMBL12528202 | 0.83 | DHODH (0.42) | DHODHCYP17A1CYP1A2TRPV1HSD11B1 | |
| SCHEMBL22315221 | 0.80 | DHODH (0.37) | DHODHCYP17A1CYP1A2TRPV1OPRL1 | |
| SCHEMBL3418088 | 0.79 | DHODH (0.38) | DHODHCYP17A1CYP1A2TRPV1HSD11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4219455-B1 | METHODS FOR THE PREPARATION OF A HALOGENATED PYRAZOLE | FMC CORP (US) | 2024-12-11 | — | — | EP | disclosed |
| US-20240300901-A1 | METHODS FOR THE PREPARATION OF 5-BROMO-2-(3-CHLORO-PYRIDIN-2-YL)-2H-PYRAZOLE-3-CARBOXYLIC ACID | FMC IP TECHNOLOGY GMBH (CH) | 2024-09-12 | — | — | US | disclosed |
| EP-4043451-B1 | METHODS FOR THE PREPARATION OF AN INTERMEDIATE IN THE SYNTHESIS OF 5-BROMO-2-(3-CHLORO-PYRIDIN-2-YL)-2H-PYRAZOLE-3-CARBOXYLIC ACID | FMC CORP (US) | 2024-02-28 | — | — | EP | disclosed |
| EP-4284793-A1 | METHODS FOR THE PREPARATION OF 5-BROMO-2-(3-CHLORO-PYRIDIN-2-YL)-2H-PYRAZOLE-3-CARBOXYLIC ACID | FMC Corporation (US) | 2023-12-06 | — | — | EP | disclosed |
| EP-4253380-A2 | METHODS FOR THE PREPARATION OF 5-BROMO-2-(3-CHLORO-PYRIDIN-2-YL)-2H-PYRAZOLE-3-CARBOXYLIC ACID | FMC Corporation (US) | 2023-10-04 | — | — | EP | disclosed |
| EP-4219455-A1 | METHODS FOR THE PREPARATION OF A HALOGENATED PYRAZOLE | FMC Corporation (US) | 2023-08-02 | — | — | EP | disclosed |
| EP-3976591-B1 | METHODS FOR THE PREPARATION OF 5-BROMO-2-(3-CHLORO-PYRIDIN-2-YL)-2H-PYRAZOLE-3-CARBOXYLIC ACID | FMC CORP (US) | 2023-04-19 | — | — | EP | disclosed |
| EP-3976589-B1 | METHODS FOR THE PREPARATION OF 5-BROMO-2-(3-CHLORO-PYRIDIN-2-YL)-2H-PYRAZOLE-3-CARBOXYLIC ACID | FMC CORP (US) | 2023-04-12 | — | — | EP | disclosed |
| US-20220396560-A1 | METHODS FOR THE PREPARATION OF 5-BROMO-2-(3-CHLORO-PYRIDIN-2-YL)-2H-PYRAZOLE-3-CARBOXYLIC ACID | FMC IP TECHNOLOGY GMBH (CH) | 2022-12-15 | — | — | US | disclosed |
| US-20220259178-A1 | METHODS FOR THE PREPARATION OF 5-BROMO-2-(3-CHLORO-PYRIDIN-2-YL)-2H-PYRAZOLE-3-CARBOXYLIC ACID | FMC IP TECHNOLOGY GMBH (CH) | 2022-08-18 | — | — | US | disclosed |
| WO-2022164871-A1 | METHODS FOR THE PREPARATION OF 5-BROMO-2-(3-CHLORO-PYRIDIN-2-YL)-2H-PYRAZOLE-3-CARBOXYLIC ACID | FMC CORPORATION (US) | 2022-08-04 | — | — | WO | disclosed |
| EP-3976589-A1 | METHODS FOR THE PREPARATION OF 5-BROMO-2-(3-CHLORO-PYRIDIN-2-YL)-2H-PYRAZOLE-3-CARBOXYLIC ACID | FMC CORPORATION (US) | 2022-04-06 | — | — | EP | disclosed |
| EP-3976591-A1 | METHODS FOR THE PREPARATION OF 5-BROMO-2-(3-CHLORO-PYRIDIN-2-YL)-2H-PYRAZOLE-3-CARBOXYLIC ACID | FMC Corporation (US) | 2022-04-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240300901-A1 | METHODS FOR THE PREPARATION OF 5-BROMO-2-(3-CHLORO-PYRIDIN-2-YL)-2H-PYRAZOLE-3-CARBOXYLIC ACID | TUBA3C, KYAT3, AADAC | DHODH 410/4885CYP17A1 1696/4885CYP1A2 48/4885 |
| US-20220259178-A1 | METHODS FOR THE PREPARATION OF 5-BROMO-2-(3-CHLORO-PYRIDIN-2-YL)-2H-PYRAZOLE-3-CARBOXYLIC ACID | KYAT3, PDXK, CBR3 | DHODH 257/4885CYP17A1 1403/4885CYP1A2 15/4885 |
| US-20220396560-A1 | METHODS FOR THE PREPARATION OF 5-BROMO-2-(3-CHLORO-PYRIDIN-2-YL)-2H-PYRAZOLE-3-CARBOXYLIC ACID | KYAT3, PDXK, CBR3 | DHODH 257/4885CYP17A1 1403/4885CYP1A2 15/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.